GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 65 filers reported holding GAMIDA CELL LTD in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,398 | -46.6% | 25,629 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $49,464 | +138.3% | 25,629 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $20,759 | +31836.9% | 25,629 | 0.0% | 0.00% | -66.7% |
| Q4 2022 | $65 | -99.8% | 25,629 | 0.0% | 0.01% | +50.0% |
| Q3 2022 | $41,000 | -8.9% | 25,629 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $45,000 | -57.5% | 25,629 | 0.0% | 0.01% | -50.0% |
| Q1 2022 | $106,000 | +63.1% | 25,629 | 0.0% | 0.01% | +66.7% |
| Q4 2021 | $65,000 | -35.0% | 25,629 | 0.0% | 0.01% | -45.5% |
| Q3 2021 | $100,000 | -22.5% | 25,629 | +4.9% | 0.01% | -26.7% |
| Q2 2021 | $129,000 | -34.8% | 24,429 | 0.0% | 0.02% | -46.4% |
| Q1 2021 | $198,000 | +17.2% | 24,429 | +28.6% | 0.03% | +7.7% |
| Q4 2020 | $169,000 | – | 19,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $9,985,000 | 2.25% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 175,000 | $721,000 | 0.56% |
| Rock Springs Capital Management LP | 2,154,300 | $8,940,000 | 0.22% |
| Laird Norton Wetherby Trust Company, LLC | 529,103 | $2,195,000 | 0.20% |
| Platform Technology Partners | 55,625 | $231,000 | 0.11% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,000,000 | $4,150,000 | 0.10% |
| Guild Investment Management, Inc. | 18,000 | $75,000 | 0.08% |
| FEDERATED HERMES, INC. | 5,128,300 | $21,282,000 | 0.05% |
| MEITAV INVESTMENT HOUSE LTD | 429,352 | $1,782,000 | 0.03% |
| 1492 Capital Management LLC | 10,000 | $42,000 | 0.02% |